Simtra BioPharma Solutions, a global CDMO specializing in injectable medicines, has acquired a 65-acre property near its Bloomington, Indiana facility to expand US manufacturing capacity, particularly for oncology-focused injectable drug products.
Simtra BioPharma Solutions | 26/07/2025 | By Mrinmoy Dey | 103
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy